A broad coalition of aging, patient, caregiver, and healthcare organizations urges congressional leaders to address concerns about how the Inflation Reduction Act (IRA)—specifically the Medicare Drug Price Negotiation Program (MDPNP)—may negatively affect older adults and people with chronic or complex conditions.
To Congress
HLC joint letter urging House and Senate leadership to enact H.R. 1492/S. 832, the “Ensuring Pathways to Innovative Cures Act.”
- Topics: Access, Innovation, Prevention
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To The Administration
Group letter to DOL on advancing the “Electronic Disclosure by Group Health Plans Under ERISA” proposed rule
Stakeholders representing employers, businesses, and environmental organizations urged the Department of Labor (DOL) to finalize its proposal to permit default electronic delivery (e-delivery) for group health plan communications under the Employee …
To Congress
Group letter urging House leadership to advance H.R. 2332/S.1101, the “SHARE Act”
HLC joined the Interstate Healthcare Collaborative and other healthcare organizations in urging House leadership to advance the bipartisan States Handling Access to Reciprocity for Employment (SHARE) Act (H.R. 2332/S. 1101). The legislation would ad…
To The Administration
Group letter to CMS opposing proposed remote monitoring restrictions in the 2027 Physician Fee Schedule
HLC also joined a coalition letter urging CMS not to finalize proposed changes to remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) in the 2027 Physician Fee Schedule proposed rule that would restrict clinically integrated …
